Miyako Igarashi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Miyako Igarashi has a total of 93 co-authors. Here are the top co-authors by number of shared publications:
Hiro Yamasaki
Department of Cardiology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan
8 shared publicationsTomoko Ishizu
Department of Cardiology, Institute of Medicine, University of Tsukuba. 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan
7 shared publicationsYuki Komatsu
Department of Cardiology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan
6 shared publicationsAkihiko Nogami
Department of Cardiology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
4 shared publications- Akihiko Nogami
Department of Cardiology Institute of Medicine, University of Tsukuba Tsukuba Japan
4 shared publications Kojiro Ogawa
Department of Cardiology, Institute of Medicine, University of Tsukuba. 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan
4 shared publications
Latest Publications
- Open Access
- 1 January 2027
- Published by XMLink in Korean Circulation Journal
- Vol. 57
Insights Into Atrial Arrhythmias After Atrial Septal Defect Closure
Igarashi M, et al. Korean Circ J. 2027 ;57:e41. https://doi.org/10.4070/kcj.2026.0264
- 1 January 2027
- Published by XMLink in Korean Circulation Journal
- Vol. 57
Open AccessInsights Into Atrial Arrhythmias After Atrial Septal Defect Closure
Igarashi M, et al. Korean Circ J. 2027 ;57:e41. https://doi.org/10.4070/kcj.2026.0264
- 18 June 2026
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 12 (9) , 2332-2336
Interatrial Dissociation Revealed by High-Density Mapping and Septal Entrainment
- 18 June 2026
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 12 (9) , 2332-2336
Interatrial Dissociation Revealed by High-Density Mapping and Septal Entrainment
- 5 May 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 153 (18) , 1439-1441
Daily Stellate Ganglion Phototherapy for Ventricular Arrhythmias: A Noninvasive Neuromodulation Approach for Outpatient Care
- 5 May 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 153 (18) , 1439-1441
Daily Stellate Ganglion Phototherapy for Ventricular Arrhythmias: A Noninvasive Neuromodulation Approach for Outpatient Care
- 28 April 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 153 (17) , 1343-1346
Effect of Empagliflozin on Device-Measured Thoracic Impedance in Patients With Type 2 Diabetes Treated With an Implantable Cardioverter Defibrillator
- 28 April 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 153 (17) , 1343-1346
Effect of Empagliflozin on Device-Measured Thoracic Impedance in Patients With Type 2 Diabetes Treated With an Implantable Cardioverter Defibrillator
- Open Access
- 20 April 2026
- Published by Elsevier in IJC Heart & Vasculature
- Vol. 64, 101930
Persistent left superior vena cava is associated with complex atrial tachyarrhythmias in repaired tetralogy of Fallot: evidence for a right-sided arrhythmogenic substrate
- 20 April 2026
- Published by Elsevier in IJC Heart & Vasculature
- Vol. 64, 101930
Open AccessPersistent left superior vena cava is associated with complex atrial tachyarrhythmias in repaired tetralogy of Fallot: evidence for a right-sided arrhythmogenic substrate
- Open Access
- 15 November 2025
- Published by Elsevier in HeartRhythm Case Reports
- Vol. 12 (2) , 196-200
Persistent left superior vena cava as a potential arrhythmogenic substrate in a patient with repaired tetralogy of Fallot
- 15 November 2025
- Published by Elsevier in HeartRhythm Case Reports
- Vol. 12 (2) , 196-200
Open AccessPersistent left superior vena cava as a potential arrhythmogenic substrate in a patient with repaired tetralogy of Fallot
- Open Access
- 15 July 2025
- Published by Elsevier in HeartRhythm Case Reports
- Vol. 11 (10) , 986-990
Successful conduction system pacing in congenitally corrected transposition of the great arteries using a 3-dimensional mapping system: A case report
- 15 July 2025
- Published by Elsevier in HeartRhythm Case Reports
- Vol. 11 (10) , 986-990
Open AccessSuccessful conduction system pacing in congenitally corrected transposition of the great arteries using a 3-dimensional mapping system: A case report
- 16 April 2025
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 36 (6) , 1386-1394
Early Corticosteroid Therapy and Its Effect on Ventricular Tachyarrhythmia Recurrence in Cardiac Sarcoidosis: A 10‐Year Longitudinal Multicenter Study
Introduction: The role of corticosteroids in the management of ventricular tachyarrhythmia (VA) in cardiac sarcoidosis (CS) remains controversial. This study assessed the effect of early steroid initiation on VA recurrence rates in patients with CS and evaluated VA frequency before and after steroid therapy.Methods: From a registry of 137 patients with CS with arrhythmias, those with VA and more than 60 days of follow‐up were included. Patients were categorized into three groups: previous‐on‐steroid, those using corticosteroids at the time of the first VA (n = 15); early‐steroid, those with steroid initiation within 60 days (n = 21); and no‐or‐delayed‐steroid, those without steroid use at 60 days from the first VA (n = 35). The VA recurrence and timing were analyzed.Results: The median age at the first VA was 60 years. Over a median follow‐up period of 81 (range: 4–345) months, 43 patients experienced VA recurrence. The median time to recurrence was 101, 33, and 17 months in the early‐steroid, no‐or‐delayed steroid, and previous‐on‐steroid groups, respectively. Corticosteroid use at 60 days was an independent predictor of VA recurrence at 120 months (hazard ratio: 2.257; p = 0.045 in the no‐or‐delayed steroid group and hazard ratio: 3.155; p = 0.021 in the previous‐on‐steroid group vs. the early‐steroid group). Low left ventricular ejection fraction (LVEF) was associated with frequent VA episodes. Corticosteroid initiation did not increase early VA episodes.Conclusion: Early corticosteroid initiation after VA onset reduced the long‐term recurrence without increasing early episodes. Cases of repetitive VA were common in those with low LVEF.
- 16 April 2025
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 36 (6) , 1386-1394
Early Corticosteroid Therapy and Its Effect on Ventricular Tachyarrhythmia Recurrence in Cardiac Sarcoidosis: A 10‐Year Longitudinal Multicenter Study
Introduction: The role of corticosteroids in the management of ventricular tachyarrhythmia (VA) in cardiac sarcoidosis (CS) remains controversial. This study assessed the effect of early steroid initiation on VA recurrence rates in patients with CS and evaluated VA frequency before and after steroid therapy.Methods: From a registry of 137 patients with CS with arrhythmias, those with VA and more than 60 days of follow‐up were included. Patients were categorized into three groups: previous‐on‐steroid, those using corticosteroids at the time of the first VA (n = 15); early‐steroid, those with steroid initiation within 60 days (n = 21); and no‐or‐delayed‐steroid, those without steroid use at 60 days from the first VA (n = 35). The VA recurrence and timing were analyzed.Results: The median age at the first VA was 60 years. Over a median follow‐up period of 81 (range: 4–345) months, 43 patients experienced VA recurrence. The median time to recurrence was 101, 33, and 17 months in the early‐steroid, no‐or‐delayed steroid, and previous‐on‐steroid groups, respectively. Corticosteroid use at 60 days was an independent predictor of VA recurrence at 120 months (hazard ratio: 2.257; p = 0.045 in the no‐or‐delayed steroid group and hazard ratio: 3.155; p = 0.021 in the previous‐on‐steroid group vs. the early‐steroid group). Low left ventricular ejection fraction (LVEF) was associated with frequent VA episodes. Corticosteroid initiation did not increase early VA episodes.Conclusion: Early corticosteroid initiation after VA onset reduced the long‐term recurrence without increasing early episodes. Cases of repetitive VA were common in those with low LVEF.
- Open Access
- 28 March 2025
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 9 (4) , ytaf170
Management of arrhythmia and heart failure in a 60-year-old with unrepaired D-transposition of the great arteries, atrial septal defect, and partial anomalous pulmonary venous return: a case report
Background: Dextro-transposition of the great arteries (d-TGA) typically results in death within the first year of life without surgery. Shunts can allow sufficient blood mixing and survival into adulthood; however, survival of patients with unrepaired d-TGA beyond 60 years has not been reported. Case summary: A 60-year-old woman with unrepaired d-TGA, an unrestricted atrial septal defect, and partial anomalous pulmonary venous return presented with recurrent syncope due to atrial tachycardia (AT) following two sessions of radiofrequency catheter ablation (RFCA) and sinus node dysfunction. She had a history of recurrent heart failure (HF) because of severe systemic right ventricle (sRV) dysfunction and tricuspid regurgitation. Multiple inducible ATs persisted even after repeated RFCA, making pacemaker implantation (PMI) and anti-arrhythmic therapy the preferred options. Although transvenous lead implantation was relatively contraindicated due to the presence of an intracardiac shunt, transvenous DDD PMI was deemed the most viable option considering the patient’s fragile haemodynamic state. Pacing studies indicated that sRV pacing was superior to left ventricular septal pacing, as it reduced the QRS duration and improved RV synchrony. Following successful sRV septal lead implantation and atrioventricular delay (AVD) optimization, HF symptoms improved, ATs were suppressed with amiodarone, and syncope resolved. The patient remained stable for 2 years with no thromboembolic events under apixaban therapy and no HF or arrhythmia recurrence. Discussion: Although continuous close monitoring is warranted, endocardial pacing, AVD optimization, and medication enabled effective stabilization over 2 years in this rare case of unrepaired d-TGA with bradytachyarrhythmia and sRV dysfunction.
- 28 March 2025
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 9 (4) , ytaf170
Open AccessManagement of arrhythmia and heart failure in a 60-year-old with unrepaired D-transposition of the great arteries, atrial septal defect, and partial anomalous pulmonary venous return: a case report
Background: Dextro-transposition of the great arteries (d-TGA) typically results in death within the first year of life without surgery. Shunts can allow sufficient blood mixing and survival into adulthood; however, survival of patients with unrepaired d-TGA beyond 60 years has not been reported. Case summary: A 60-year-old woman with unrepaired d-TGA, an unrestricted atrial septal defect, and partial anomalous pulmonary venous return presented with recurrent syncope due to atrial tachycardia (AT) following two sessions of radiofrequency catheter ablation (RFCA) and sinus node dysfunction. She had a history of recurrent heart failure (HF) because of severe systemic right ventricle (sRV) dysfunction and tricuspid regurgitation. Multiple inducible ATs persisted even after repeated RFCA, making pacemaker implantation (PMI) and anti-arrhythmic therapy the preferred options. Although transvenous lead implantation was relatively contraindicated due to the presence of an intracardiac shunt, transvenous DDD PMI was deemed the most viable option considering the patient’s fragile haemodynamic state. Pacing studies indicated that sRV pacing was superior to left ventricular septal pacing, as it reduced the QRS duration and improved RV synchrony. Following successful sRV septal lead implantation and atrioventricular delay (AVD) optimization, HF symptoms improved, ATs were suppressed with amiodarone, and syncope resolved. The patient remained stable for 2 years with no thromboembolic events under apixaban therapy and no HF or arrhythmia recurrence. Discussion: Although continuous close monitoring is warranted, endocardial pacing, AVD optimization, and medication enabled effective stabilization over 2 years in this rare case of unrepaired d-TGA with bradytachyarrhythmia and sRV dysfunction.